AR008095A1 - Indanilidinacetilguanidinas sustituidas, procedimiento para su preparacion, su uso en la preparacion de medicamentos o agentes de diagnosticoasi como medicamento que las contienen - Google Patents
Indanilidinacetilguanidinas sustituidas, procedimiento para su preparacion, su uso en la preparacion de medicamentos o agentes de diagnosticoasi como medicamento que las contienenInfo
- Publication number
- AR008095A1 AR008095A1 ARP970103414A ARP970103414A AR008095A1 AR 008095 A1 AR008095 A1 AR 008095A1 AR P970103414 A ARP970103414 A AR P970103414A AR P970103414 A ARP970103414 A AR P970103414A AR 008095 A1 AR008095 A1 AR 008095A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- substituted
- procedure
- indanilidineacetilguanidines
- medicines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C327/54—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Indanilidinacetilguanidinas sustituidas de la fórmula (I) y sus sales farmacéuticamente aceptables, en las que X es O, S o NH y R1, R2, R3, R4, R5,R6, R7, R8, R9, R10 tienen los significados dados en las reivindicaciones, son inhibidoresefect ivos del antiporte celular sodio/protón (intercambiador Na+/H+) que en numerosas enfermedades (hipertensión esencial, aterosclorosis, diabetes y similares) está también incrementado en aquellas células que sonfácilmente accesibles paramedidas, tales como, por ejemplo, en eritrocitos, plaquetas o leucocitos. También son útiles para la preparación de unmedicamento para el tratamiento o profilaxis de trastornos del metabolismo de los lípidos. Se describe un procedimientopara su prep aración ymedicamentos que las contienen.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96112275A EP0837055A1 (en) | 1996-07-30 | 1996-07-30 | Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008095A1 true AR008095A1 (es) | 1999-12-09 |
Family
ID=8223055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103414A AR008095A1 (es) | 1996-07-30 | 1997-07-28 | Indanilidinacetilguanidinas sustituidas, procedimiento para su preparacion, su uso en la preparacion de medicamentos o agentes de diagnosticoasi como medicamento que las contienen |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5900436A (es) |
| EP (2) | EP0837055A1 (es) |
| JP (1) | JP4039589B2 (es) |
| KR (1) | KR980009236A (es) |
| CN (1) | CN1064351C (es) |
| AR (1) | AR008095A1 (es) |
| AT (1) | ATE207888T1 (es) |
| AU (1) | AU715187B2 (es) |
| BR (1) | BR9704131A (es) |
| CA (1) | CA2211982C (es) |
| CZ (1) | CZ241197A3 (es) |
| DE (1) | DE69707777T2 (es) |
| DK (1) | DK0822182T3 (es) |
| ES (1) | ES2164283T3 (es) |
| HR (1) | HRP970424B1 (es) |
| HU (1) | HUP9701316A3 (es) |
| ID (1) | ID17565A (es) |
| IL (1) | IL121407A0 (es) |
| MX (1) | MX9705737A (es) |
| NO (1) | NO308213B1 (es) |
| NZ (1) | NZ328440A (es) |
| PL (1) | PL321392A1 (es) |
| PT (1) | PT822182E (es) |
| RU (1) | RU2176638C2 (es) |
| SI (1) | SI0822182T1 (es) |
| SK (1) | SK282128B6 (es) |
| TR (1) | TR199700704A2 (es) |
| TW (1) | TW445251B (es) |
| ZA (1) | ZA976735B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010078449A2 (en) | 2008-12-31 | 2010-07-08 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| GB0916163D0 (en) * | 2009-09-15 | 2009-10-28 | Shire Llc | Prodrugs of guanfacine |
| HUE044550T2 (hu) | 2013-04-12 | 2019-11-28 | Ardelyx Inc | NHE-3 megkötõ vegyületek és foszfát transzport gátlási módszerek |
| CN110267944B (zh) | 2017-01-09 | 2024-03-08 | 阿德利克斯股份有限公司 | 可用于治疗胃肠道病症的化合物 |
| JP2020505333A (ja) | 2017-01-09 | 2020-02-20 | アルデリックス， インコーポレイテッド | Ｎｈｅ媒介性アンチポートの阻害薬 |
| WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| DE4421536A1 (de) * | 1994-06-20 | 1995-12-21 | Hoechst Ag | Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1996
- 1996-07-30 EP EP96112275A patent/EP0837055A1/en not_active Withdrawn
-
1997
- 1997-05-23 TW TW086106928A patent/TW445251B/zh active
- 1997-07-14 ID IDP972422A patent/ID17565A/id unknown
- 1997-07-24 EP EP97112674A patent/EP0822182B1/en not_active Expired - Lifetime
- 1997-07-24 ES ES97112674T patent/ES2164283T3/es not_active Expired - Lifetime
- 1997-07-24 DK DK97112674T patent/DK0822182T3/da active
- 1997-07-24 DE DE69707777T patent/DE69707777T2/de not_active Expired - Lifetime
- 1997-07-24 PT PT97112674T patent/PT822182E/pt unknown
- 1997-07-24 AT AT97112674T patent/ATE207888T1/de not_active IP Right Cessation
- 1997-07-24 SI SI9730260T patent/SI0822182T1/xx unknown
- 1997-07-28 TR TR97/00704A patent/TR199700704A2/xx unknown
- 1997-07-28 AU AU31554/97A patent/AU715187B2/en not_active Ceased
- 1997-07-28 US US08/901,099 patent/US5900436A/en not_active Expired - Lifetime
- 1997-07-28 KR KR1019970035527A patent/KR980009236A/ko not_active Application Discontinuation
- 1997-07-28 SK SK1034-97A patent/SK282128B6/sk unknown
- 1997-07-28 CN CN97114777A patent/CN1064351C/zh not_active Expired - Fee Related
- 1997-07-28 AR ARP970103414A patent/AR008095A1/es unknown
- 1997-07-28 IL IL12140797A patent/IL121407A0/xx unknown
- 1997-07-28 NZ NZ328440A patent/NZ328440A/en unknown
- 1997-07-28 CZ CZ972411A patent/CZ241197A3/cs unknown
- 1997-07-29 PL PL97321392A patent/PL321392A1/xx unknown
- 1997-07-29 ZA ZA9706735A patent/ZA976735B/xx unknown
- 1997-07-29 HU HU9701316A patent/HUP9701316A3/hu unknown
- 1997-07-29 RU RU97113146/04A patent/RU2176638C2/ru not_active IP Right Cessation
- 1997-07-29 MX MX9705737A patent/MX9705737A/es not_active IP Right Cessation
- 1997-07-29 JP JP20275697A patent/JP4039589B2/ja not_active Expired - Fee Related
- 1997-07-29 CA CA002211982A patent/CA2211982C/en not_active Expired - Fee Related
- 1997-07-29 HR HR970424A patent/HRP970424B1/xx not_active IP Right Cessation
- 1997-07-29 NO NO973486A patent/NO308213B1/no not_active IP Right Cessation
- 1997-07-29 BR BR9704131A patent/BR9704131A/pt active Search and Examination
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2063011T3 (es) | Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente. | |
| IS3156A7 (is) | Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar | |
| DE3576912D1 (de) | Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung. | |
| MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
| AR029383A1 (es) | Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes | |
| ES2158413T3 (es) | Alquenoilguanididas sustituidas con fenilo, procedimiento para su preparacion, su uso como farmacos o en agentes de diagnostico y medicamentos que las contienen. | |
| AR003938A1 (es) | Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos. | |
| ES2188595T3 (es) | Derivados del acido 1-(2-oxo-acetil)-piperidin-2-carboxilico como sensibilizadores de celulas cancerosas resistentes a multiples farmacos. | |
| ATE84032T1 (de) | Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| DE68913762D1 (de) | Diarylverbindungen als antiatherosklerotische Mittel. | |
| ATE38991T1 (de) | In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
| BR0014826A (pt) | Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm | |
| AR008095A1 (es) | Indanilidinacetilguanidinas sustituidas, procedimiento para su preparacion, su uso en la preparacion de medicamentos o agentes de diagnosticoasi como medicamento que las contienen | |
| ES2149403T3 (es) | Benciloxicarbonilguanidinas sustituidas como inhibidores del intercambiador de protones de sodio, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
| ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
| DK429480A (da) | Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel | |
| BR9601989A (pt) | Indenoilguanidinas processo para sua preparação seus usos e medicamento | |
| FR2700166B1 (fr) | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. | |
| MX9300203A (es) | Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene. | |
| ES2122962T3 (es) | Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia. | |
| BR0014680A (pt) | Pirróis substituìdos como agentes antiproliferativos para o tratamento de câncer | |
| UY26485A1 (es) | "pirroles sustituidos" | |
| ES2055440T3 (es) | Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2064948T3 (es) | Polimetilen-iminas disustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| AR026242A1 (es) | Empleo de 2-amino-3,4-dihidro-quinazolinas para la preparacion de un medicamento para el tratamiento o profilaxis de enfermedades provocadas por estadosisquemicos |